← FDA Drug Approvals (Drugs@FDA)
TRIUMEQ PD
NDA · New Drug Application · Sponsor: VIIV HLTHCARE · Approved 2022-03-30
Drug application
- FDA Application #
NDA215413- Application type
- New Drug Application
- Brand name
- TRIUMEQ PD
- Generic name
- ABACAVIR SULFATE, DOLUTEGRAVIR SODIUM, LAMIVUDINE
- Active ingredients
- ABACAVIR SULFATE; DOLUTEGRAVIR SODIUM; LAMIVUDINE
- Dosage form
- TABLET, FOR SUSPENSION
- Route
- ORAL
- Marketing status
- Prescription
- Sponsor
- VIIV HLTHCARE
- Manufacturer
- ViiV Healthcare Company
- First approval
- 2022-03-30
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown